(Q27682070)

8

object named as

Gary J Nabel

0 references

Hadi M Yassine

3

object named as

Hadi M Yassine

0 references

Jeffrey C Boyington

6

object named as

Jeffrey C Boyington

0 references

author name string

Daniel Lingwood

1

0 references

Patrick M McTamney

2

0 references

James R R Whittle

4

0 references

Chih-Jen Wei

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

7

0 references

language of work or name

English

0 references

publication date

27 September 2012

0 references

published in

Nature

0 references

volume

489

0 references

page(s)

566-70

0 references

issue

7417

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Standard conformations for the canonical structures of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

The serine and threonine residues in the Ig-alpha cytoplasmic tail negatively regulate immunoreceptor tyrosine-based activation motif-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

It's all about change: the antigen-driven initiation of B-cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Evidence for a preformed transducer complex organized by the B cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE11371

Transmembrane signaling: the joy of aggregation

21 January 2018

1 reference

12 December 2020

Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen

1 reference

12 December 2020

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

1 reference

12 December 2020

Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.

1 reference

12 December 2020

Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine

1 reference

12 December 2020